ACTRN12616000163404已完成未知
A pilot 'proof of concept' study to evaluate the effect of an innovative web-based resource, NSW Synergy Online Ecosystem, on general health and wellbeing in young Australians aged 16 to 25 years in three locations (Western Sydney, Central Coast and Far West).
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 25 Years（—）
- 性别
- All
入选标准
- •Each participant must meet all of the following criteria to be enroled in the study:
- •* Aged 16 to 25 years old;
- •* Currently live in the NSW target communities of the Central Coast, Western Sydney or Far West;
- •* Regular access to a smartphone (iPhone or Android) and the Internet; and,
- •* Willingness to give online informed consent and willingness to comply with study protocol.
排除标准
- •Due to the naturalistic research design, this study does not have defined exclusion criteria.
研究者
相似试验
进行中（未招募）
1 期
The effect of lanreotide on therapy resistant gastro-esophageal refluxpatients with persistent endoscopic reflux in spite of maximal medical therapy with PPI 2 x 40 mg pantoprazole before breakfast and dinner and 300 mg of H2 blocker ranitidine at bedtime AND continuing pathological reflux proven on impedancemetry.MedDRA version: 14.1Level: LLTClassification code 10017924Term: Gastroesophageal refluxSystem Organ Class: 100000004856EUCTR2013-004232-29-BEZ Brussel15
招募中
不适用
Open pilot trial of a prototype emotional wellbeing app for adolescentsAnxietyDepressionACTRN12618000273280niversity of Auckland40
进行中（未招募）
1 期
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa. - EVADEPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 20.0Level: LLTClassification code 10051190Term: Pneumonia Pseudomonas aeruginosaSystem Organ Class: 100000004862EUCTR2015-001706-34-HUMedImmune, LLC188
进行中（未招募）
1 期
Clinical trial looking at the safety and efficacy of MEDI3902 in the prevention of Pseudomonas aeruginosa pneumonia occurring in the hospitalPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 18.1Level: LLTClassification code 10051190Term: Pneumonia Pseudomonas aeruginosaSystem Organ Class: 100000004862EUCTR2015-001706-34-DEMedImmune, LLC429
进行中（未招募）
1 期
Clinical trial looking at the safety and efficacy of MEDI3902 in the prevention of Pseudomonas aeruginosa pneumonia occurring in the hospitalPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 20.0 Level: LLT Classification code 10051190 Term: Pneumonia Pseudomonas aeruginosa System Organ Class: 100000004862EUCTR2015-001706-34-CZMedImmune, LLC429